VolkerWilhelmStieberMD

Clinical Trials

• Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases Start of enrollment: 2004 Jan 01

  Completed

  Phase 2

• Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2003 Oct 01

  Completed

  Phase 1

• Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma Start of enrollment: 2004 Jan 01

  Completed

  Phase 2

• Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors Start of enrollment: 2002 Jun 01

  Completed

  Phase 1, Phase 2

• Radiation Boost for Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2006 Aug 01

  Terminated

  Phase 1, Phase 2

• Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer Start of enrollment: 2007 Jan 01

  Withdrawn

  Phase 1, Phase 2

• Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme Start of enrollment: 2014 May 01

  Completed

  Phase 1, Phase 2

• Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08

  Active, not recruiting

  Not Applicable

  Roles: Contact

• Join now to see all